Table 3.
Baseline clinical and microbiological characteristics of the study sample (n = 60).
| Total sample (n = 60) | Active (n = 40) | Placebo (n = 20) | p value | ||
|---|---|---|---|---|---|
| Clinical and microbiological characteristics | |||||
| Vulvovaginal signs and symptoms | Leucorrhoea | 57 (95.00%) | 37 (92.50%) | 20 (100.00%) | 0.54 |
| Burning | 49 (81.67%) | 32 (80.00%) | 17 (85.00%) | 0.73 | |
| Itching | 47 (78.33%) | 31 (77.50%) | 16 (80.00%) | 1.00 | |
| Vulvovaginal Erythema/Edema | 43 (71.67%) | 28 (70.00%) | 15 (75.00%) | 0.77 | |
| Subjective vulvar discomfort | 56 (93.33%) | 36 (90.00%) | 20 (100.00%) | 0.29 | |
| Amsel Criteria | Homogenous vaginal discharge | 54 (90.00%) | 35 (87.50%) | 19 (95.00%) | 0.65 |
| Clue cell presence | 42 (70.00%) | 25 (62.50%) | 17 (85.00%) | 0.08 | |
| Positive amine test | 32 (53.33%) | 14 (35.00%) | 18 (90.00%) | <0.005 | |
| Vaginal pH > 4.5 | 37 (61.67%) | 20 (50.00%) | 17 (85.00%) | 0.01 | |
| Nugent score | 0–3 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1.00 |
| 4–6 | 1 (0,16%) | 0 (0.00%) | 1 (5.00%) | 0.33 | |
| 7–10 | 59 (98.33%) | 40 (100.00%) | 19 (95.00%) | 0.33 | |
| Lactobacillary grade | I | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1.00 |
| II | 20 (33.33%) | 12 (30.00%) | 8 (40.00%) | 0.56 | |
| III | 40 (66.67%) | 28 (70.00%) | 12 (60.00%) | 0.56 | |
Data are presented as means ± SD and percentages.